Dexrazoxane (ICRF-187) protects cardiac myocytes against doxorubicin by preventing damage to mitochondria
- 作者Brian B. Hasinoff; Kareena L. Schnabl; Rosemary A. Marusak; Daywin Patel; Erwin Huebner
- 卷第3卷
- 期第2期
- 印刷ISSN1530-7905
- 文件大小245.21KB
- 发表时间2003
- DOI10.1385/ct:3:2:89
- 页码89-99
Tocolysis, β2 agonists and anaesthesiaS. J. Rodgers; M. Morgan · 1994
Long-acting β2-agonistsA. E. TATTERSFIELD · 1992
β2-Agonists and bronchial hyperresponsivenessClive P. Page; Domenico Spina · 2006
Clinical concerns with inhaled β2-agonistsD. W. Cockcroft · 2006
β2-Agonists for asthmaPadmaja Subbarao; Felix Ratjen · 2006
Interactions between corticosteroids and β2-agonistsRobert J. Hancox · 2006
β2-Agonists at the olympic gamesKenneth D. Fitch · 2006
β2-Agonists and exercise-induced asthmaSandra D. Anderson; Corinne Caillaud; John D. Brannan · 2006
Monitoring asthma therapy using indirect bronchial provocation testsJohn D. Brannan; Heikki Koskela; Sandra D. Anderson · 2007
Exercise-induced bronchoconstriction: PathogenesisSandra D. Anderson; Pascale Kippelen · 2005
Exercise-induced asthmaSandra D. Anderson; Michael Silverman; Peter König; Simon Godfrey · 1975
Exercise-Induced bronchoconstrictionAnderson, Sandra D. · Immunology and Allergy Clinics of North America · 2013
Indirect Challenge TestsAnderson, Sandra D. · CHEST Journal · 2010
DecentralizationHamilton, D. Kirk; Swoboda, Sandra M.; Lee, Jin-Ting; Anderson, Diana C. · Critical Care Nursing Quarterly · 2018